Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-18-004751
Filing Date
2018-04-20
Accepted
2018-04-20 11:08:30
Documents
1
Period of Report
2018-05-24
Effectiveness Date
2018-04-20

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT def14a0418_immudyne.htm DEF 14A 147026
  Complete submission text file 0001213900-18-004751.txt   148115
Mailing Address 1460 BROADWAY NEW YORK NY 10036
Business Address 1460 BROADWAY NEW YORK NY 10036 914-244-1777
Immudyne, Inc. (Filer) CIK: 0000948320 (see all company filings)

EIN.: 760238453 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-55857 | Film No.: 18765494
SIC: 2833 Medicinal Chemicals & Botanical Products